1-20 of 2544
Save search
Sort by
Journal Article

Bleeding and thrombosis

PDF
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 211–212, https://doi.org/10.1093/ehjcvp/pvaf017
Published: 02 May 2025
Journal Article
ACCEPTED MANUSCRIPT

News in cardiovascular pharmacotherapy from the ACC.25 Meeting

PDF
Eva Delpón and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf029, https://doi.org/10.1093/ehjcvp/pvaf029
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Stroke risk stratifications according to CHA2DS2-VASc vs. CHA2DS2-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry

PDF
Steven Ho Man Lam and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf031, https://doi.org/10.1093/ehjcvp/pvaf031
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice

PDF
Felice Gragnano and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf032, https://doi.org/10.1093/ehjcvp/pvaf032
Published: 26 April 2025
Image
Graphical Abstract

Graphical Abstract

Published: 26 April 2025
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis

PDF
Xuan Ci Mee and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf026, https://doi.org/10.1093/ehjcvp/pvaf026
Published: 26 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis

PDF
Giuseppina Novo and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf028, https://doi.org/10.1093/ehjcvp/pvaf028
Published: 25 April 2025
Image
Graphical Abstract

Graphical Abstract

Published: 25 April 2025
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT

Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants

PDF
Shun Sasaki and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf030, https://doi.org/10.1093/ehjcvp/pvaf030
Published: 24 April 2025
Image
Graphical Abstract

Graphical Abstract

Published: 24 April 2025
Graphical Abstract Graphical Abstract
Image
Graphical abstract

Graphical abstract

Published: 24 April 2025
Graphical abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis

PDF
Damien Legallois and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf027, https://doi.org/10.1093/ehjcvp/pvaf027
Published: 24 April 2025
Journal Article

Early initiation of SGLT2 inhibitors after acute myocardial infarction

PDF
Andeas Hammer and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf020, https://doi.org/10.1093/ehjcvp/pvaf020
Published: 18 April 2025
Image
Overview of the EMPACT-MI and DAPA-MI trials. Legend: A brief overview of ...

Overview of the EMPACT-MI and DAPA-MI trials. Legend: A brief overview of ...

Published: 18 April 2025
Figure 1 Overview of the EMPACT-MI and DAPA-MI trials. Legend: A brief overview of the DAPA-MI and EMPACT-MI trials. Abbreviations: AFIB, atrial fibrillation; CI, confidence interval; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio; LVEF, left ventricular ejection fraction; MI, myocardial infarct
Journal Article
ACCEPTED MANUSCRIPT

Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies

PDF
Filippo Luca Gurgoglione and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf025, https://doi.org/10.1093/ehjcvp/pvaf025
Published: 12 April 2025
Journal Article

Correction to: Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

PDF
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Page 318, https://doi.org/10.1093/ehjcvp/pvaf013
Published: 08 April 2025
Journal Article

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies

PDF
Andrea Rubboli and others
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf021, https://doi.org/10.1093/ehjcvp/pvaf021
Published: 02 April 2025
Image
Antithrombotic therapy for CCS patients and new-onset VTE with indication (...

Antithrombotic therapy for CCS patients and new-onset VTE with indication (...

Published: 02 April 2025
Figure 2 Antithrombotic therapy for CCS patients and new-onset VTE with indication (A) or not (B) for indefinite OAC. CCS, chronic coronary syndrome; VTE, venous thromboembolism; SAPT, single antiplatelet therapy; DAPT, dual antiplatelet therapy; DAT, double antithrombotic therapy; OAC, oral anticoagulation;
Image
Antithrombotic therapy for CCS patients with new-onset AF. CCS, chronic cor...

Antithrombotic therapy for CCS patients with new-onset AF. CCS, chronic cor...

Published: 02 April 2025
Figure 1 Antithrombotic therapy for CCS patients with new-onset AF. CCS, chronic coronary syndrome; AF, atrial fibrillation; OD, once daily; SAPT, single antiplatelet therapy; DAPT, dual antiplatelet therapy; DAT, double antithrombotic therapy; OAC, oral anticoagulation; DOAC, direct oral anticoagulant.
Image
Kaplan Meier estimates of the primary outcome. IPW analysis. Kaplan Meier e...

Kaplan Meier estimates of the primary outcome. IPW analysis. Kaplan Meier e...

Published: 01 April 2025
Figure 2 Kaplan Meier estimates of the primary outcome. IPW analysis. Kaplan Meier estimates of (all cause death, MI, ischaemic stroke, or stent thrombosis) at 30 days according to the pre-treatment strategy groups.